Vfend and bronchopulmonary aspergillosis Patient Reports February 12, 2012

Vfend Side Effects Report #4912776-5
Vfend side effect was reported by a Physician from FRANCE on Feb 02, 2006. Male patient, 42 years of age, was diagnosed with prophylaxis, graft versus host disease and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, cerebral ischaemia, cerebrovascular accident, cerebrovascular disorder, coma, cytomegalovirus gastritis, fungal infection , gastric ulcer, gastritis erosive. Vfend dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS. Patient was hospitalized. Patient died.

Vfend Side Effects Report #4656621-4
Vfend side effect was reported by a Physician from on Apr 25, 2005. Female patient was diagnosed with ill-defined disorder, transplant, bacterial infection  and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, cholestasis, confusional state, disorientation, hallucination, hallucinations, mixed, somnolence, transaminases abnormal. Vfend dosage: 800 MG (4X INTERVAL: EVERYDAY), INTRAVENOUS. During the same period patient was treated with DIFLUCAN, MORPHINE, ACYCLOVIR, CEFEPIME HYDROCHLORIDE, CYCLOSPORINE, LORAZEPAM, CITALOPRAM HYDROBROMIDE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #4903426-2
Vfend side effect was reported by a Physician from JAPAN on Jan 23, 2006. Male patient, 83 years of age, weighting 70.99 lb, was diagnosed with bronchopulmonary aspergillosis, gastric ulcer, constipation , hypokalaemia, dysphagia and was treated with Vfend. After drug was administered, patient experienced the following side effects: abasia, anorexia, aphonia, atypical mycobacterial infection, blood glucose decreased, bronchopulmonary aspergillosis, cardiac arrest , cerebrovascular disorder, depressed level of consciousness. Vfend dosage: 180 MG (3 MG/KG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with FAMOTIDINE, PURSENNID, ASPARA K, SYMMETREL, LAXOBERON. Patient was hospitalized. Patient died on 01/05/2006.

Vfend Side Effects Report #5104038-0
Vfend side effect was reported by a Physician from JAPAN on Aug 28, 2006. Male patient, 77 years of age, weighting 92.59 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: bacterial infection , blood pressure decreased, body temperature increased, bronchopulmonary aspergillosis, condition aggravated, dehydration, heart rate decreased, hyperthermia, hypokalaemia. Vfend dosage: 400 MG, ORAL. During the same period patient was treated with CEFOBID, POTACOL. Patient died on 08/05/2006.


Vfend Side Effects Report #5118563-X
Vfend side effect was reported by a Physician from JAPAN on Sept 15, 2006. Male patient, 77 years of age, weighting 92.59 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: bacterial infection , blood pressure decreased, bronchopulmonary aspergillosis, condition aggravated, dehydration, hyperthermia, hypokalaemia, oral intake reduced. Vfend dosage: 400 MG, ORAL. During the same period patient was treated with CEFOBID, POTACOL. Patient died on 08/05/2006.

Vfend Side Effects Report #4644815-3
Vfend side effect was reported by a Pharmacist from on Apr 11, 2005. Female patient, 76 years of age, weighting 140.0 lb, was diagnosed with bronchopulmonary aspergillosis, staphylococcal infection  and was treated with Vfend. After drug was administered, patient experienced the following side effects: anuria, bronchopulmonary aspergillosis, haemodialysis, oedema, renal impairment, weight increased. Vfend dosage: 700 MG (350 MG, 1 IN 12 HR), INTRAVENOUS. During the same period patient was treated with AMPHOTERICIN B, VANCOMYCIN, MOXIFLOXACIN, PREDNISONE, LEPIRUDIN, MAGNESIUM SULPHATE, ERYTHROMYCIN, NYSTATIN. Patient was hospitalized. Patient died on 01/21/2005.

Vfend Side Effects Report #5144581-1
Vfend side effect was reported by a Physician from JAPAN on Oct 18, 2006. Male patient, 57 years of age, weighting 112.4 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood pressure immeasurable, bronchopulmonary aspergillosis, cardiac arrest , condition aggravated, eye rolling, feeling abnormal, heart rate decreased. Vfend dosage: 400 MG (200 MG, FREQUENCY: BID), INTRAVENOUS. During the same period patient was treated with CEFTAZIDIME, FIRSTCIN, CARBENIN, SAXIZON, OMEPRAL, MUCOSTA, LASIX, FUNGIZONE. Patient was hospitalized. Patient died on 09/05/2006.

Vfend Side Effects Report #5153652-5
Vfend side effect was reported by a Physician from JAPAN on Nov 02, 2006. Male patient, 57 years of age, weighting 112.4 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood pressure immeasurable, bronchopulmonary aspergillosis, cardiac arrest , condition aggravated, hodgkin's disease , hypoglycaemia, loss of consciousness, lymphadenitis. Vfend dosage: 400 MG (200 MG, FREQUENCY: BID), INTRAVENOUS. During the same period patient was treated with AMINOPHYLLINE, MODACIN, FIRSTCIN, CARBENIN, SAXIZON, OMEPRAL, MUCOSTA, LASIX. Patient was hospitalized. Patient died on 09/05/2006.

Vfend Side Effects Report #5255634-1
Vfend side effect was reported by a Consumer or non-health professional from JAPAN on Feb 21, 2007. Female patient, 45 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, cerebral haemorrhage, disease recurrence, endocarditis , liver abscess, renal abscess, systemic candida. Vfend dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE, FLUDARABINE, MELPHALAN, TACROLIMUS. Patient died.


Vfend Side Effects Report #5154362-0
Vfend side effect was reported by a Physician from FRANCE on Oct 30, 2006. Female patient, 29 years of age, was diagnosed with bronchopulmonary aspergillosis, lung transplant  and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, cholangitis, cholecystitis, cholelithiasis, sphincter of oddi dysfunction. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, CYCLOSPORINE, PREDNISONE. Patient recovered.

Vfend Side Effects Report #5271673-9
Vfend side effect was reported by a Physician from JAPAN on Sept 15, 2006. Male patient, weighting 92.59 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, condition aggravated, pyrexia, rhabdomyolysis. Vfend dosage: DAILY DOSE:400MG. During the same period patient was treated with CEFOBID, POTACOL. Patient died on 08/05/2006.

Vfend Side Effects Report #5826297-9
Vfend side effect was reported by a Pharmacist from JAPAN on July 17, 2008. Male patient, weighting 97.00 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, hypoglycaemia. Vfend dosage: DAILY DOSE:200MG. During the same period patient was treated with LENDORMIN, MYSLEE, AMBISOME, LOXONIN. Patient was hospitalized. Patient died on 07/16/2008.

Vfend Side Effects Report #5834400-X
Vfend side effect was reported by a Pharmacist from JAPAN on July 24, 2008. Male patient, weighting 97.00 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, hypoglycaemia. Vfend dosage: DAILY DOSE:200MG. During the same period patient was treated with LENDORMIN, MYSLEE, AMBISOME, LOXONIN. Patient was hospitalized. Patient died on 07/16/2008.

Vfend Side Effects Report #4804474-3
Vfend side effect was reported by a Physician from JAPAN on Oct 04, 2005. Female patient was diagnosed with bronchopulmonary aspergillosis, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, chromatopsia, delirium, dizziness , haemorrhagic diathesis, international normalised ratio increased, nausea , prothrombin time prolonged. Vfend dosage: 400 MG, ORAL. During the same period patient was treated with WARFARIN, ITRACONAZOLE. Patient recovered.


Vfend Side Effects Report #4874841-0
Vfend side effect was reported by a Physician from JAPAN on Dec 20, 2005. Female patient was diagnosed with bronchopulmonary aspergillosis, atrial fibrillation  and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, condition aggravated, delirium, dizziness , haemorrhagic diathesis, international normalised ratio increased, nausea , pulmonary haemorrhage. Vfend dosage: 400 MG, ORAL; 200 MG, ORAL. During the same period patient was treated with WARFARIN, ITRACONAZOLE. Patient recovered.

Vfend Side Effects Report #5132427-7
Vfend side effect was reported by a Physician from JAPAN on Oct 04, 2006. Male patient, 71 years of age, weighting 111.1 lb, was diagnosed with aspergillosis, bacterial infection  and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, condition aggravated, interstitial lung disease, multiple myeloma , pneumocystis jiroveci pneumonia. Vfend dosage: 140 MG (2 IN 1 D), INTRAVENOUS. During the same period patient was treated with MAXIPIME, PURSENNID, OMEPRAZOLE, TAMSULOSIN, LOXONIN, APLACE, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 08/26/2006.

Vfend Side Effects Report #4596605-8
Vfend side effect was reported by a Physician from on Feb 14, 2005. Male patient, 55 years of age, was diagnosed with aspergillosis, endocarditis bacterial, cytomegalovirus infection  and was treated with Vfend. After drug was administered, patient experienced the following side effects: aplasia, aspergillosis, bronchopulmonary aspergillosis, cholestasis, endocarditis bacterial, histiocytosis haematophagic, multi-organ failure, toxic epidermal necrolysis. Vfend dosage: unknown. During the same period patient was treated with AMOXICILLIN, AMPHOTERICIN B, GENTAMICIN, GANCICLOVIR, FOSCARNET, BACTRIM, PANTOPRAZOLE, PREDNISONE. Patient was hospitalized. Patient died on 01/14/2005.

Vfend Side Effects Report #4622336-1
Vfend side effect was reported by a Physician from on Mar 16, 2005. Male patient, 55 years of age, was diagnosed with aspergillosis, endocarditis bacterial, cytomegalovirus infection , ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, cholestasis, endocarditis bacterial, febrile bone marrow aplasia, histiocytosis haematophagic, multi-organ failure, toxic epidermal necrolysis. Vfend dosage: unknown. During the same period patient was treated with AMOXICILLIN, AMPHOTERICIN B, GENTAMICIN SULPHATE, GANCICLOVIR, FOSCARNET, PANTOPRAZOLE. Patient was hospitalized. Patient died on 01/14/2005.

Vfend Side Effects Report #4948708-3
Vfend side effect was reported by a Physician from FRANCE on Feb 28, 2006. Male patient, 35 years of age, was diagnosed with aspergillosis, febrile bone marrow aplasia, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: alveolitis, bronchopulmonary aspergillosis, febrile bone marrow aplasia, klebsiella infection, mucormycosis, pulmonary infarction, systemic mycosis. Vfend dosage: 400 MG (2 IN 1 D), ORAL. During the same period patient was treated with CASPOFUNGIN, AMPHOTERICIN B, AXEPIM, AMIKIN, TIENAM, CIPROFLAXACIN, CANCIDAS, CYTARABINE. Patient recovered.


Vfend Side Effects Report #4701784-5
Vfend side effect was reported by a Consumer or non-health professional from on June 14, 2005. Female patient, child 11 years of age, weighting 97.00 lb, was diagnosed with aspergillosis, leukaemia and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back pain , blood alkaline phosphatase increased, blood bilirubin increased, bronchopulmonary aspergillosis, flushing, headache . Vfend dosage: 200 MG (100 MG 2 IN 1 D) INTRAVENOUS; 300 MG (150 MG 2 IN 1 D INTRAVENOUS). During the same period patient was treated with ASPARGINASE, MERCAPTOPURINE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5967570-3
Vfend side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Nov 13, 2008. Male patient, weighting 141.1 lb, was diagnosed with aspergillosis, liver disorder, hyperplasia, mineral supplementation, gastroduodenal ulcer, antifungal treatment, pyrexia, pain  and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis. Vfend dosage: unknown. During the same period patient was treated with URSODIOL, TAMSULOSIN, POTASSIUM CHLORIDE, RABEPRAZOLE, ITRACONAZOLE, ZOLPIDEM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5967577-6
Vfend side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Nov 13, 2008. Male patient, weighting 114.6 lb, was diagnosed with aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis. Vfend dosage: unknown. Patient was hospitalized. Patient recovered.